A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center

Category: Prophylaxis

  • Xarelto (Rivaroxaban) – FDA Approved

    On July 1st, the FDA approved the oral blood thinner Xarelto (rivaroxaban) for the prevention of deep vein thrombosis (DVT) in patients undergoing  knee or hip replacement surgery.

  • Long Distance Travel and Blood Clots

    Background and Summary Long distance travel, either by plane, car, bus or train, is a slight risk factor for DVT (deep vein thrombosis) and PE (pulmonary embolism). The risk is low. However, there are some people who are at higher risk. In these people compression stockings and/or an injection of a low-dose “blood thinner” (low…